Amide compounds derived from NDAZOL-4-Carboxilico and 1-H-Pirazolo [3,4-C] pyridine-4-carboxilico, potentiator of CCR1 receptor, pharmacological synthesis, effective means for treating chronic inflammation, allergy, cortical inflammation, rheumatic arthritis, multiple sclerosis and type 1 diabetes, Among other things.
COOK, BRIAN NICHOLAS,KUZMICH, DANIEL,MAO, CAN,RAZAVI, HOSSEIN
申请号：
CL2012000967
公开号：
CL2012000967A1
申请日:
2012.04.16
申请国别(地区):
CL
年份:
2012
代理人:
摘要：
F amp； oacute； rmula (I) refers to the target country of F amp (ccrl) receiver； oacute； rmula (I) refers to the target country of ARL, arz, RL, X and G, as described in the description and claim documents； CI amp； oacute； n pharmacist and amp； eacute； use of these compounds and use of F amp compound； oacute； Used in the treatment of inflammation TemporalAnaphylaxis, sorias, rheumatoid arthritis, sclerosing M amp； uacute； the last type of diabetes, type 1, etc.； br / gt；[Chinese explanation]: ampere, NBS, lt, / P gt<；p>；LA PRESENTE INVENCIÓ；N SE REFIERE A ANTAGONISTAS DEL RECEPTOR DE CCRL DE LA FÓ；RMULA (I) EN DONDE ARL, ARZ, RL, X Y G SON COMO SE DESCRIBEN EN LA MEMORIA DESCRIPTIVA Y PLIEGO DE REIVINDICACIONES； COMPOSICIÓ；N FARMACÉ；UTICA DE LOS MISMOS Y USO DE LOS COMPUESTOS DE LA FÓ；RMULA (I) EN EL TRATAMIENTO DE INFLAMACIONES. CRONICAS,, ALERGIAS, SORIASIS, ARTRITIS REUMATOIDEA, ESCLEROSIS MÚ；LTIPLE, DIABETES TIPO 1, ENTRE OTRAS.<；br />； ；<；/p>；
